12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Aileron, Roche preclinical data

In in vivo and in vitro models of cancer, ATSP-7041 reactivated the p53-dependent pathway, induced p53-dependent apoptosis and inhibited cell proliferation. ATSP-7041 is a selective

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >